Preferential Th1 cytokine profile of phosphoantigen-stimulated human v 9V 2 T cells

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Doherty, Derek G ^a,b   Dunne, Margaret R ^a,b,c   Mangan, Bozgana A ^a   Madrigal Estebas, Laura ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHYL BUT 2 ENYL PYROPHOSPHATE; ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; ISOPENTENYL DIPHOSPHATE; PHOSPHOANTIGEN; UNCLASSIFIED DRUG; 4 HYDROXY 3 METHYLBUT 2 ENYL PYROPHOSPHATE; 4-HYDROXY-3-METHYLBUT-2-ENYL PYROPHOSPHATE; CYTOKINE; HEMITERPENE; INTERLEUKIN DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR; ORGANOPHOSPHORUS COMPOUND; PYROPHOSPHATE; T CELL RECEPTOR VDELTA2, HUMAN; T CELL RECEPTOR VGAMMA9, HUMAN; T-CELL RECEPTOR VDELTA2, HUMAN; T-CELL RECEPTOR VGAMMA9, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; BIOSYNTHESIS; DRUG EFFECT; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS; CYTOKINES; DIPHOSPHATES; HEMITERPENES; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKINS; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954988989     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/704941     Document Type: Article

References (51)

1. Morita C. T., Jin C., Sarikonda G., Wang H., Nonpeptide antigens, presentation mechanisms, and immunological memory of human V 2V 2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens Immunological Reviews 2007 215 1 59 76 (Pubitemid 46212230)
2. Moser B., Eberl M., T cells: novel initiators of adaptive immunity Immunological Reviews 2007 215 1 89 102 (Pubitemid 46212232)
3. Cipriani B., Borsellino G., Poccia F., Placido R., Tramonti D., Bach S., Battistini L., Brosnan C. F., Activation of C-C -chemokines in human peripheral blood T cells by isopentenyl pyrophosphate and regulation by cytokines Blood 2000 95 1 39 47 (Pubitemid 30017222)
4. Dieli F., Troye-Blomberg M., Ivanyi J., Fourni J. J., Krensky A. M., Bonneville M., Peyrat M. A., Caccamo N., Sireci G., Salerno A., Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by V- 9/V 2 T lymphocytes Journal of Infectious Diseases 2001 184 8 1082 1085 (Pubitemid 32955129)
5. Wrobel P., Shojaei H., Schittek B., Gieseler F., Wollenberg B., Kalthoff H., Kabelitz D., Wesch D., Lysis of a broad range of epithelial tumour cells by human T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition Scandinavian Journal of Immunology 2007 66 2-3 320 328 (Pubitemid 47063194)
6. Lehner T., Mitchell E., Bergmeier L., The role of T cells in generating antiviral factors and -chemokines in protection against mucosal simian immunodeficiency virus infection European Journal of Immunology 2000 30 8 2245 2256
7. Dudal S., Turriere C., Bessoles S., Fontes P., Sanchez F., Liautard J., Liautard J. P., Lafont V., Release of LL-37 by activated human V 9V 2 T cells: a microbicidal weapon against Brucella suis Journal of Immunology 2006 177 8 5533 5539 (Pubitemid 44527627)
8. Workalemahu G., Foerster M., Kroegel C., Expression and synthesis of fibroblast growth factor-9 in human T-lymphocytes. Response to isopentenyl pyrophosphate and TGF- 1/IL-15 Journal of Leukocyte Biology 2004 75 4 657 663 (Pubitemid 38405657)
9. Workalemahu G., Foerster M., Kroegel C., Braun R. K., Human -T lymphocytes express and synthesize connective tissue growth factor: effect of IL-15 and TGF- 1 and comparison with -T lymphocytes Journal of Immunology 2003 170 1 153 157 (Pubitemid 36026135)
10. Agrati C., Cimini E., Sacchi A., Bordoni V., Gioia C., Casetti R., Turchi F., Tripodi M., Martini F., Activated V 9V 2 T cells trigger granulocyte functions via MCP-2 release Journal of Immunology 2009 182 1 522 529
11. Caccamo N., Battistini L., Bonneville M., Poccia F., Fourni J. J., Meraviglia S., Borsellino G., Kroczek R. A., La Mendola C., Scotet E., Dieli F., Salerno A., CXCR5 identifies a subset of V 9V 2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production Journal of Immunology 2006 177 8 5290 5295 (Pubitemid 44527601)
12. Eberl M., Roberts G. W., Meuter S., Williams J. D., Topley N., Moser B., A rapid crosstalk of human T cells and monocytes drives the acute inflammation in bacterial infections PLoS Pathogens 2009 5 2
13. Ismaili J., Olislagers V., Poupot R., Fourni J. J., Goldman M., Human T cells induce dendritic cell maturation Clinical Immunology 2002 103 3 296 302 (Pubitemid 34666753)
14. Conti L., Casetti R., Cardone M., Varano B., Martino A., Belardelli F., Poccia F., Gessani S., Reciprocal activating interaction between dendritic cells and pamidronate-stimulated T cells: role of CD86 and inflammatory cytokines Journal of Immunology 2005 174 1 252 260 (Pubitemid 40007411)
15. Devilder M. C., Maillet S., Bouyge-Moreau I., Bonnadieu E., Bonneville M., Scotet E., Potentiation of antigen-stimulated V 9V 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation Journal of Immunology 2006 176 3 1386 1393 (Pubitemid 43134280)
16. Dunne M. R., Madrigal-Estebas L., Tobin L. M., Doherty D. G., (E)-4-hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated V 9V 2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived dendritic cells Cancer Immunology, Immunotherapy 2010 59 7 1109 1120
17. Brandes M., Willimann K., Moser B., Immunology: professional antigen-presentation function by human cells Science 2005 309 5732 264 268 (Pubitemid 40967855)
18. Meuter S., Eberl M., Moser B., Prolonged antigen survival and cytosolic export in cross-presenting human T cells Proceedings of the National Academy of Sciences of the United States of America 2010 107 19 8730 8735
19. Fisch P., Malkovsky M., Kovats S., Sturm E., Braakman E., Klein B. S., Voss S. D., Morrissey L. W., DeMars R., Welch W. J., Bolhuis R. L. H., Sondel P. M., Recognition by human V 9V 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells Science 1990 250 4985 1269 1273 (Pubitemid 120031842)
20. Viey E., Fromont G., Escudier B., Morel Y., Da Rocha S., Chouaib S., Caignard A., Phosphostim-activated T cells kill autologous metastatic renal cell carcinoma Journal of Immunology 2005 174 3 1338 1347
21. Mattarollo S. R., Kenna T., Nieda M., Nicol A. J., Chemotherapy and zoledronate sensitize solid tumour cells to V 9V 2 T cell cytotoxicity Cancer Immunology, Immunotherapy 2007 56 8 1285 1297 (Pubitemid 46763941)
22. Wilhelm M., Kunzmann V., Eckstein S., Reimer P., Weissinger F., Ruediger T., Tony H. P., T cells for immune therapy of patients with lymphoid malignancies Blood 2003 102 1 200 206 (Pubitemid 36759655)
23. Bennouna J., Bompas E., Neidhardt E. M., Rolland F., Philip I., Gala C., Salot S., Saiagh S., Audrain M., Rimbert M., Lafaye-De Micheaux S., Tiollier J., Ngrier S., Phase-I study of Innacell, an autologous cell-therapy product highly enriched in V 9V 2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma Cancer Immunology, Immunotherapy 2008 57 11 1599 1609
24. Kobayashi H., Tanaka Y., Shimmura H., Minato N., Tanabe K., Complete remission of lung metastasis following adoptive immunotherapy using activated autologous T-cells in a patient with renal cell carcinoma Anticancer Research 2010 30 2 575 579
25. Nakajima J., Murakawa T., Fukami T., Goto S., Kaneko T., Yoshida Y., Takamoto S., Kakimi K., A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous T cells European Journal of Cardio-Thoracic Surgery 2010 37 5 1191 1197
26. Dieli F., Vermijlen D., Fulfaro F., Caccamo N., Meraviglia S., Cicero G., Roberts A., Buccheri S., D'Asaro M., Gebbia N., Salerno A., Eberl M., Hayday A. C., Targeting human T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer Cancer Research 2007 67 15 7450 7457 (Pubitemid 47206575)
27. Gober H. J., Kistowska M., Angman L., Jen P., Mori L., De Libero G., Human T cell receptor cells recognize endogenous mevalonate metabolites in tumor cells Journal of Experimental Medicine 2003 197 2 163 168 (Pubitemid 36152311)
28. Ferrick D. A., Schrenzel M. D., Mulvania T., Hsieh B., Ferlin W. C., Lepper H., Differential production of interferon- and interleukin-4 in response to Th1- and Th2-stimulating pathogens by T cells in vivo Nature 1995 373 6511 255 257
29. Wen L., Barber D. F., Pao W., Wong F. S., Owen M. J., Hayday A., Primary cell clones can be defined phenotypically and functionally as Th1/Th2 cells and illustrate the association of CD4 with Th2 differentiation Journal of Immunology 1998 160 4 1965 1974 (Pubitemid 28106487)
30. Hayday A., Tigelaar R., Immunoregulation in the tissues by T cells Nature Reviews Immunology 2003 3 3 233 242
31. Martin B., Hirota K., Cua D. J., Stockinger B., Veldhoen M., Interleukin-17-producing T cells selectively expand in response to pathogen products and environmental signals Immunity 2009 31 2 321 330
32. Sutton C. E., Lalor S. J., Sweeney C. M., Brereton C. F., Lavelle ED. C., Mills K. H. G., Interleukin-1 and IL-23 induce innate IL-17 production from T cells, amplifying Th17 responses and autoimmunity Immunity 2009 31 2 331 341
33. Garca V. E., Sieling P. A., Gong J., Barnes P. F., Uyemura K., Tanaka Y., Bloom B. R., Morita C. T., Modlin R. L., Single-cell cytokine analysis of T cell responses to nonpeptide mycobacterial antigens Journal of Immunology 1997 159 3 1328 1335 (Pubitemid 127484111)
34. Tsukaguchi K., De Lange B., Boom W. H., Differential regulation of IFN-, TNF-, and IL-10 production by CD4+TCR+ T cells and V 2 T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra Cellular Immunology 1999 194 1 12 20
35. Wesch D., Glatzel A., Kabelitz D., Differentiation of resting human peripheral blood T cells toward Th1- or Th2-phenotype Cellular Immunology 2001 212 2 110 117 (Pubitemid 34044542)
36. Eberl M., Engel R., Beck E., Jomaa H., Differentiation of human T cells towards distinct memory phenotypes Cellular Immunology 2002 218 1-2 1 6 (Pubitemid 36027085)
37. Angelini D. F., Borsellino G., Poupot M., Diamantini A., Poupot R., Bernardi G., Poccia F., Fourni J. J., Battistini L., Fc RIII discriminates between 2 subsets of V 9V 2 effector cells with different responses and activation pathways Blood 2004 104 6 1801 1807 (Pubitemid 39202290)
38. Vermijlen D., Ellis P., Langford C., Klein A., Engel R., Willimann K., Jomaa H., Hayday A. C., Eberl M., Distinct cytokine-driven responses of activated blood T cells: insights into unconventional T cell pleiotropy Journal of Immunology 2007 178 7 4304 4314 (Pubitemid 46492381)
39. Ness-Schwickerath K. J., Jin C., Morita C. T., Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human V 9V 2 T cells Journal of Immunology 2010 184 12 7268 7280
40. Hintz M., Reichenberg A., Altincicek B., Bahr U., Gschwind R. M., Kollas A. K., Beck E., Wiesner J., Eberl M., Jomaa H., Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human T cells in Escherichia coli FEBS Letters 2001 509 2 317 322 (Pubitemid 34015963)
41. Eberl M., Hintz M., Reichenberg A., Kollas A. K., Wiesner J., Jomaa H., Microbial isoprenoid biosynthesis and human T cell activation FEBS Letters 2003 544 13 4 10 (Pubitemid 36628027)
42. Reichenberg A., Hintz M., Kletschek Y., Kuhl T., Haug C., Engel R., Moll J., Ostrovsky D. N., Jomaa H., Eberl M., Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates its potential to activate human T cells but does not lead to competitive antagonism Bioorganic and Medicinal Chemistry Letters 2003 13 7 1257 1260 (Pubitemid 36355933)
43. Doherty D. G., Norris S., Madrigal-Estebas L., McEntee G., Traynor O., Hegarty J. E., O'Farrelly C., The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns Journal of Immunology 1999 163 4 2314 2321 (Pubitemid 29382243)
44. Correia D. V., D'Orey F., Cardoso B. A., Lana T., Grosso A. R., DeBarros A., Martins L. R., Barata J. T., Silva-Santos B., Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human T-cells PLoS One 2009 4 5
45. Pietschmann K., Beetz S., Welte S., Martens I., Gruen J., Oberg H. H., Wesch D., Kabelitz D., Toll-like receptor expression and function in subsets of human T lymphocytes Scandinavian Journal of Immunology 2009 70 3 245 255
46. Shojaei H., Oberg H. H., Juricke M., Marischen L., Kunz M., Mundhenke C., Gieseler F., Kabelitz D., Wesch D., Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human T cells Cancer Research 2009 69 22 8710 8717
47. Bauer S., Groh V., Wu J., Steinle A., Phillips J. H., Lanier L. L., Spies T., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 1999 285 5428 727 729
48. Tanaka Y., Morita C. T., Tanaka Y., Nieves E., Brenner M. B., Bloom B. R., Natural and synthetic non-peptide antigens recognized by human T cells Nature 1995 375 6527 155 158
49. Bendelac A., Savage P. B., Teyton L., The biology of NKT cells Annual Review of Immunology 2007 25 297 336 (Pubitemid 46697911)
50. Morita C. T., Beckman E. M., Bukowski J. F., Tanaka Y., Band H., Bloom B. R., Golan D. E., Brenner M. B., Direct presentation of nonpeptide prenyl pyrophosphate antigens to human T cells Immunity 1995 3 4 495 507
51. Lafarge X., Pitard V., Ravet S., Roumanes D., Halary F., Dromer C., Vivier E., Paul P., Moreau J. F., Dchanet-Merville J., Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of T cells European Journal of Immunology 2005 35 6 1896 1905 (Pubitemid 40862338)